U.S. Cosmetics Imports and FDA Compliance

Entering the United States Cosmetics Market

The United States is one of the world’s largest markets for cosmetics, beauty products, personal-care products, fragrances, skin-care preparations, hair-care products, nail products, and related consumer goods. It is also a market in which product classification, claims, safety, labeling, establishment information, and import records can determine whether a shipment enters smoothly or becomes subject to detention, examination, refusal, reconditioning, destruction, or re-export.

For decades, companies often described U.S. cosmetics regulation as less demanding than the regulatory systems applied to drugs or medical devices. That description is now incomplete. The Modernization of Cosmetics Regulation Act of 2022, commonly known as MoCRA, created the most significant expansion of federal cosmetics oversight since the Federal Food, Drug, and Cosmetic Act of 1938. It established mandatory facility registration and cosmetic product listing requirements, strengthened adverse-event reporting, required safety substantiation, expanded FDA records-access and recall authority, and directed the agency to develop additional rules involving cosmetic good manufacturing practices, fragrance allergens, and talc testing.

The same compliance principles apply whether a business is located in California, Florida, France, Japan, South Africa, Brazil, South Korea, Canada, or elsewhere. A domestic manufacturer must comply before distributing products in interstate commerce. A foreign manufacturer must also satisfy applicable U.S. requirements before its products are shipped, offered for import, sold through a distributor, delivered to a fulfillment center, or marketed directly to American consumers.

This guide focuses on cosmetics, but it is also relevant to food manufacturers, exporters, importers, and distributors that have expanded into beauty or personal-care lines. A company that already understands food registration, prior notice, FSVP, or food labeling should not assume that the same regulatory roles and submissions apply to cosmetics. Cosmetics operate under a different statutory framework, different product classifications, and different compliance responsibilities.

MoCRA and the Modern U.S. Cosmetics Framework

MoCRA changed cosmetics compliance from a largely post-market model into a system that includes mandatory federal submissions and documented responsibilities. The law does not establish ordinary premarket approval for cosmetic products, but it gives FDA more visibility into the facilities, products, ingredients, safety records, and responsible persons participating in the U.S. market.

Cosmetic product manufacturers and processors that are not exempt must register their facilities with FDA. Registration information must be updated when required, and the registration must be renewed every two years. For foreign facilities, the submission includes a designated U.S. agent who serves as a communications contact for FDA. This role is not merely a mailing address. The contact must be able to receive agency communications and coordinate promptly with the foreign establishment.

The “responsible person”—the manufacturer, packer, or distributor whose name appears on the cosmetic label—must submit cosmetic product listings. Each listing includes required product and ingredient information and identifies the facilities where the product is manufactured or processed. Changes must be handled through annual updates, including information showing that a marketed product has been discontinued.

MoCRA also requires adequate substantiation of cosmetic product safety. The responsible person should maintain records supporting a reasonable certainty that the product is safe under labeled or customary conditions of use. This may involve toxicological assessments, ingredient reviews, microbiological controls, stability information, preservative effectiveness data, compatibility testing, exposure assessments, supplier documentation, and other scientifically relevant evidence.

Serious adverse events associated with cosmetic products used in the United States must be reported to FDA within 15 business days after the responsible person receives the report. A copy of the product label must accompany the submission. New medical or other relevant information received within one year of the initial report must also be submitted within the applicable reporting period.

Facility Registration, Product Listing, and U.S. Agent Support

A compliant submission process begins with accurate legal names, physical addresses, business roles, contact details, and FDA Establishment Identifier information. A responsible person cannot reliably complete a product listing without identifying the facility or facilities where the product is manufactured or processed.

Foreign establishments should select a U.S. agent that understands cosmetics regulation and can communicate efficiently. The agent may receive questions, notices, or other communications from FDA. Delayed responses can create avoidable problems, particularly when the company is already dealing with a shipment, an inspection, a records request, or a registration discrepancy.

Facility registration and product listing data should be managed as living records rather than one-time forms. Changes in ownership, address, contract manufacturer, formulation, product discontinuation, label name, or responsible-person information may require updates. Businesses should maintain a regulatory calendar that distinguishes biennial facility renewal from annual product-listing maintenance.

• Verify the legal facility name and physical manufacturing address.
• Confirm whether the site manufactures, processes, fills, packs, or only stores products.
• Obtain or verify the applicable FEI information.
• Identify the responsible person shown on each label.
• Compile ingredient statements and product-category information.
• Identify every facility associated with each listed cosmetic product.
• Maintain annual listing updates and discontinuation records.
• Calendar biennial facility-registration renewal deadlines.

Cosmetic Safety, Ingredients, and Manufacturing Controls

Cosmetic products and most cosmetic ingredients are not individually approved by FDA before marketing. Color additives are the major exception: they must be approved for their intended use, and certain color additives must come from FDA-certified batches. A company cannot rely solely on the fact that an ingredient is popular, natural, traditional, organic, permitted in another country, or sold by a reputable supplier.

The manufacturer and responsible person should evaluate ingredient identity, purity, concentration, intended use, route of exposure, foreseeable misuse, vulnerable populations, contaminants, interactions, packaging compatibility, and cumulative exposure. Products used near the eyes, on mucous membranes, on children, or on damaged skin may warrant greater scrutiny.

Microbiological contamination remains a significant import and enforcement concern. Water-based cosmetics, creams, lotions, mascaras, cleansers, and products packaged in jars or applicators may be vulnerable to contamination if preservation, sanitation, raw-material controls, equipment cleaning, environmental monitoring, or packaging integrity is inadequate. Manufacturers should establish written procedures appropriate to their operation and maintain evidence that the system works consistently.

Although FDA’s future cosmetics GMP rulemaking may add more detailed federal requirements, companies should not postpone basic controls. Sound practices include approved suppliers, written specifications, incoming-material checks, batch records, equipment cleaning, line clearance, in-process controls, finished-product testing, deviation review, complaint investigation, traceability, change control, and recall readiness.

U.S. Cosmetic Labeling and Marketing Claims

A compliant label is more than an attractive package. It communicates product identity, net quantity, responsible-party information, ingredients, warnings, directions when needed, and other required statements in a manner that is prominent, truthful, and not misleading. Imported products generally need required information in English, although additional languages may be used when handled correctly.

The principal display panel should clearly identify what the product is and provide the net quantity of contents. Information-panel requirements generally include the name and place of business of the manufacturer, packer, or distributor, together with an ingredient declaration using accepted nomenclature and descending order rules, subject to applicable exceptions.

MoCRA added a requirement for domestic contact information through which the responsible person can receive adverse-event reports. Products intended only for professional use must also meet applicable professional-use labeling requirements. Companies should evaluate both the physical package and all promotional material, including marketplace listings, websites, social media, influencer scripts, brochures, videos, and search-engine metadata.

Claims are one of the most frequent sources of misclassification. A skin cream may be a cosmetic when promoted to moisturize or improve appearance. The same cream may become a drug when promoted to treat eczema, increase collagen production in a way that changes skin structure, heal wounds, or relieve inflammation. A hair product promoted to add shine is cosmetic; a product promoted to regrow hair is a drug.

How FDA Reviews Imported Cosmetics

FDA works with U.S. Customs and Border Protection to monitor imported products. Cosmetics offered for entry may be reviewed through electronic screening, document requests, label examination, sampling, laboratory testing, facility history, importer history, country risk, product risk, or an applicable import alert. FDA does not need to prove a final violation before taking import action; an article may be refused when it appears to be adulterated or misbranded.

Foreign cosmetics that appear noncompliant may be detained. The importer may have an opportunity to provide evidence, request reconditioning, relabel the goods under appropriate supervision, export the shipment, or destroy it, depending on the circumstances. These options cost time and money and may disrupt retailer commitments, launch dates, marketplace availability, or seasonal promotions.

Common reasons for import problems include illegal or uncertified color additives, microbial contamination, missing ingredient declarations, inaccurate identity statements, therapeutic claims, incomplete English labeling, unsafe ingredients, undisclosed manufacturing information, and inconsistencies between entry data and the actual shipment.

1. Before productionConfirm U.S. product classification, formula acceptability, color-additive status, and manufacturing controls.
2. Before printingReview labels, claims, responsible-person details, ingredient declarations, warnings, and domestic adverse-event contact information.
3. Before shipmentVerify facility registration, product listing, U.S. agent information, commercial invoice descriptions, manufacturer identity, and entry documentation.
4. At entryEnsure the importer and customs broker can respond quickly to FDA requests and provide consistent supporting records.
5. After releaseMaintain distribution records, complaints, adverse-event procedures, product-listing updates, and recall readiness.

Special Issues for Importers, Distributors, and Online Sellers

Importers and distributors may not formulate or manufacture the product, but they can still create or magnify compliance risk. A U.S. distributor whose name appears on the label may be the responsible person. A retailer that adds disease claims to a product page may cause the item to be regulated as a drug. An online seller that changes the product name, images, or directions can create a mismatch between the physical label and the marketing presentation.

Private-label arrangements require particular attention. The foreign factory may manufacture the product, a U.S. brand owner may control the label, a third-party warehouse may hold inventory, and an online marketplace may handle fulfillment. Each party should know who maintains registration, listing, formula, safety, complaint, and adverse-event records.

Companies that also import foods or dietary supplements should keep regulatory systems separate where needed. Cosmetic facility registration is not food facility registration. Cosmetic product listing is not food prior notice. A cosmetics U.S. agent is not automatically an FSVP importer. The Importer of Record under customs law is not necessarily the responsible person under MoCRA. One company may hold several roles, but the roles should not be confused.

Building a Practical Cosmetics Compliance Program

A strong program begins with a complete inventory of products, formulas, facilities, labels, claims, suppliers, and responsible parties. The company should then assign ownership for every recurring obligation. Without assigned responsibility, annual product-listing updates, biennial facility renewals, complaint follow-up, and label changes can be overlooked.

Management should create a regulatory file for each product or product family. The file should include the approved formula, ingredient documentation, supplier records, manufacturing specifications, finished-product criteria, safety substantiation, stability and microbiological information, packaging artwork, claims approval, listing evidence, distribution records, complaint history, and change-control documentation.

Importers should maintain a pre-shipment review process. No shipment should leave the foreign facility until the importer confirms that the physical labels match the approved artwork, the commercial documents accurately identify the product and manufacturer, the facility data remain current, and the product listing is complete. High-risk or first-time shipments may warrant photographs, batch records, certificates of analysis, microbiological results, or color-additive documentation before departure.

Training is also essential. Marketing teams should understand that attractive therapeutic language can change product classification. Customer-service teams should know how to recognize and escalate possible serious adverse events. Warehouses should maintain lot traceability. Quality personnel should know when a formula, supplier, label, or packaging change requires regulatory review.

• Product classification and claims approval procedure
• Facility registration and renewal calendar
• Product listing and annual update calendar
• Safety substantiation documentation
• Supplier qualification and ingredient specifications
• Batch, sanitation, and release records
• Complaint and serious adverse-event procedure
• Recall, traceability, and crisis-communication plan
• Pre-shipment import compliance review
• Change control for formulas, labels, claims, and facilities

Compliance Protects Market Access

U.S. cosmetics compliance is no longer limited to checking whether an ingredient is banned or whether a label looks acceptable. MoCRA has created mandatory registration, listing, safety, recordkeeping, adverse-event, and contact obligations. FDA’s import system can also identify problems before products reach consumers, and the consequences of a noncompliant shipment may include detention, refusal, reconditioning, destruction, or re-export.

Domestic and foreign manufacturers, processors, exporters, importers, distributors, retailers, brand owners, and online sellers should treat compliance as a coordinated supply-chain function. The facility that manufactures the product, the company whose name appears on the label, the importer that enters the shipment, and the seller that promotes the product all influence regulatory risk.

Companies that also handle foods, dietary supplements, OTC drugs, or medical devices must identify the correct FDA framework for each product. Existing experience in one regulated category is valuable, but it does not replace category-specific analysis. A clear classification decision, accurate submissions, compliant labeling, documented safety, and reliable communications can prevent costly mistakes and create a stronger foundation for long-term U.S. sales.